Canopy Growth (CGC) EBT Growth (1y) (2020 - 2025)
Canopy Growth (CGC) EBT Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -24.84% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1,578.91% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 262.69% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -342.95% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 62.03% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 248.00% |
| 10 | Canopy Growth | 11.16 Mn | -137.54 Mn | 15.39 Mn | 48.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48.70% |
| Sep 30, 2025 | 98.92% |
| Jun 30, 2025 | 66.91% |
| Mar 31, 2025 | 652.68% |
| Dec 31, 2024 | 48.79% |
| Sep 30, 2024 | 4.70% |
| Jun 30, 2024 | -1,312.67% |
| Mar 31, 2024 | 115.68% |
| Dec 31, 2023 | -1.09% |
| Sep 30, 2023 | 30.06% |
| Jun 30, 2023 | 99.61% |
| Mar 31, 2023 | -57.31% |
| Dec 31, 2022 | -83.17% |
| Sep 30, 2022 | -829.94% |
| Jun 30, 2022 | -612.43% |
| Mar 31, 2022 | 33.27% |
| Dec 31, 2021 | 85.84% |
| Sep 30, 2021 | 78.45% |
| Jun 30, 2021 | 437.35% |
| Mar 31, 2021 | -121.23% |